Having trouble viewing this email? View the online version. Unsubscribe.
SexHealthMatters logo
email-top-stripe
ED Drugs Not Linked to Prostate Cancer Recurrence

Pills for erectile dysfunction (ED) don't increase a man's risk for biochemical recurrence of prostate cancer, according to new research. 

These medications, which include Viagra, Levitra, and Cialis, are often one of the first ED treatments men try. 

Past research had raised some concerns about a possible link. For this new study, published in European Urology in December, scientists analyzed five years of data from about 6,000 men with prostate cancer. 

They found no connection between ED pills and biochemical prostate cancer recurrence. 

"Biochemical recurrence" refers to elevated levels of prostate-specific antigen (PSA) in the blood.  This can be a sign that cancer is coming back. 

Ready to learn more? Just click here. 

Sexual Concerns After Breast Cancer Treatment

Lower sexual interest, trouble with lubrication, and painful intercourse are just some of the potential sexual health challenges faced by breast cancer survivors.

Such problems can vary with the type of treatment. For example, women who have radiation therapy may lose some of the sexual sensation in their skin.

Fortunately, help is available. Recently, the American Cancer Society and the American Society of Clinical Oncology published their Breast Cancer Survivorship Guideline, which is designed to help healthcare providers meet the overall health needs of survivors, including sexual health.

Get all the details here.

 

You are receiving this newsletter because you are subscribed to our mailing list.
If you would rather not receive emails like this in the future you can unsubscribe.

Sexhealthmatters.org | Sexual Medicine Society of North America, Inc.
PO Box 1233, Lakeville, MN 55044

healthcommunities.com